ARABINOSYL CYTOSINE (ARA-C) ENHANCED M-AMSA-INDUCED DNA CLEAVAGE AND CYTOTOXICITY IN M-AMSA SENSITIVE AND RESISTANT HUMAN-LEUKEMIA CELLS BUT DID NOT COMPLETELY OVERCOME M-AMSA RESISTANCE

被引：0
|
作者：
BAKIC, M [1 ]
BERAN, M [1 ]
ANDERSSON, B [1 ]
CHAN, D [1 ]
ESTEY, E [1 ]
ZWELLING, L [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DIV MED,HOUSTON,TX 77030
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1986年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：261 / 261
页数：1
相关论文
共 21 条
  • [1] REDUCED M-AMSA-INDUCED, TOPOISOMERASE (TOPO) II-MEDIATED DNA CLEAVAGE AS AN INDICATOR OF M-AMSA RESISTANCE IN HUMAN-LEUKEMIA
    ESTEY, E
    FREIREICH, EJ
    KHADEMI, T
    ZWELLING, LA
    CLINICAL RESEARCH, 1986, 34 (02): : A562 - A562
  • [2] M-AMSA-INDUCED TOPOISOMERASE-II (TOPO II)-MEDIATED DNA CLEAVAGE - AN INDICATOR OF SENSITIVITY TO M-AMSA IN HUMAN-LEUKEMIA CELLS
    ESTEY, E
    SILBERMAN, L
    BAKIC, M
    BERAN, M
    ANDERSSON, B
    ADLAKHA, R
    FREIREICH, E
    ZWELLING, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 261 - 261
  • [3] INTERMEDIATE-DOSE ARA-C M-AMSA FOR REMISSION INDUCTION AND HIGH-DOSE ARA-C M-AMSA FOR INTENSIVE CONSOLIDATION IN RELAPSED AND REFRACTORY ADULT ACUTE MYELOGENOUS LEUKEMIA (AML)
    JEHN, U
    HEINEMANN, V
    WILMANNS, W
    ANTICANCER RESEARCH, 1989, 9 (01) : 119 - 124
  • [4] HIGH-DOSES OF ARA-C AND M-AMSA IN THE TREATMENT OF REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA
    LATAGLIATA, R
    PETTI, MC
    SPIRITI, MAA
    MELONI, G
    SGADARI, C
    TORROMEO, C
    VEGNA, ML
    MANDELLI, F
    HAEMATOLOGICA, 1990, 75 (03) : 249 - 251
  • [5] M-AMSA - EFFECTS ON NEOPLASTIC CELLULAR PROLIFERATION INVIVO IN HUMAN-LEUKEMIA AND LYMPHOMA
    HANSEN, H
    ARLIN, Z
    FRIED, J
    YEN, A
    CLARKSON, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 179 - 179
  • [6] DOXORUBICIN AND M-AMSA INDUCED DNA DAMAGE IN BLAST CELLS FROM AML PATIENTS
    LIMONTA, M
    UBEZIO, P
    CATAPANO, CV
    CONTER, V
    COSTATO, C
    MASERA, G
    SPECCHIA, G
    LISO, V
    BARBUI, T
    GIUDICI, G
    DINCALCI, M
    LEUKEMIA RESEARCH, 1991, 15 (01) : 19 - 24
  • [7] RESISTANCE TO 4'-(9-ACRIDINYLAMINO) METHANESULPHON-M-ANISIDIDE (M-AMSA) IN HUMAN MYELOID-LEUKEMIA
    SKINNER, WL
    MURRAY, D
    KOHLI, V
    BERAN, M
    MCCREDIE, KB
    FREIREICH, EJ
    ANDERSSON, BS
    BRITISH JOURNAL OF CANCER, 1990, 61 (01) : 51 - 55
  • [8] THE PRODUCTION OF TOPOISOMERASE-II-MEDIATED DNA CLEAVAGE IN HUMAN-LEUKEMIA CELLS PREDICTS THEIR SUSCEPTIBILITY TO 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (M-AMSA)
    BAKIC, M
    BERAN, M
    ANDERSSON, BS
    SILBERMAN, L
    ESTEY, E
    ZWELLING, LA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (02) : 638 - 645
  • [9] DECREASED NUCLEAR MATRIX DNA TOPOISOMERASE-II IN HUMAN LEUKEMIA-CELLS RESISTANT TO VM-26 AND M-AMSA
    FERNANDES, DJ
    DANKS, MK
    BECK, WT
    BIOCHEMISTRY, 1990, 29 (17) : 4235 - 4241
  • [10] SALVAGE THERAPY WITH METHYL-GAG, HIGH-DOSE ARA-C, M-AMSA, AND IFOSFAMIDE (MAMI) FOR RECURRENT OR REFRACTORY LYMPHOMA
    HAYAT, M
    OSTRONOFF, M
    GILLES, E
    ZAMBON, E
    BAUME, D
    MORAN, A
    CARDE, P
    DROZ, JP
    PICO, JL
    CANCER INVESTIGATION, 1990, 8 (01) : 1 - 5
123